INL is the lead entity for international drug demand reduction in the U.S. government. Over three decades of implementation, INL has developed a program on the cutting edge of demand-reduction science, backed by evidence-based outcome evaluations that document concrete, measurable results. Constantly emerging threats related to substance abuse, such as unprecedented child drug addiction and new, dangerous forms of crack cocaine, require vigilance for identifying issues and agility in responding to these crises. The INL demand reduction program consists of five core program components:
Drug-Free Community Coalition Program: Assists civil society and grassroots organizations in key drug producing countries to form and sustain effective community anti-drug coalitions that address illegal drugs. Target Areas: Mexico, Latin America, Asia, and Africa.
Regional Training - Treatment: Utilizes a core, nine-week curricula to both train and certify addictions treatment specialists. Target Regions: Africa, South America, Central Asia, Southeast/Southwest Asia, and Central America/Mexico.
Regional Training - Prevention: New initiative that will develop five one-week courses to both train and certify prevention specialists for schools and communities. Target sub-regions: the Caribbean, South America, and Central America.
Women’s Drug Treatment Initiative: Supports the continued development of gender-sensitive training curriculum, such as novel intervention services for addicted women, follow-on training assistance, advocacy, research, and demonstration programs that address the unique needs and closes the treatment gap of female addicts worldwide. Target Regions: Latin America, Africa, Asia.
Child Drug Addiction Initiative: Supports development of the world’s first drug treatment protocols and related curricula for drug addicted children (infancy - 12 years of age) in Latin America (crack cocaine), Southwest Asia (opiates), and Afghanistan (opiates).